Invesaro

Stocks Comparison

Axogen vs Medtronic: revenue, profit, margins and growth compared

Axogen brought in $225.2M of revenue in fiscal 2025, Medtronic $36.4B in fiscal 2026. Revenue changed by +20.2% at Axogen and +8.4% at Medtronic on the year before, so Axogen grew faster. Axogen kept -7.0% of its revenue as net profit, Medtronic 13.2%. Free cash flow was -$2.9M at Axogen and $5.4B at Medtronic.

Side by side, latest fiscal year

AXGNMDT
Fiscal year endedFY2025 (December 31, 2025)FY2026 (April 24, 2026)
Revenue$225.2M$36.4B
Revenue growth+20.2%+8.4%
Net income-$15.7M$4.8B
Net margin-7.0%13.2%
Free cash flow-$2.9M$5.4B
Free cash flow margin-1.3%14.9%
Earnings per share (diluted)-$0.34$3.73
Cash$35.5M$1.9B
Debt$48.4M$26.2B
Price to earningsn/a23.8
Market value$2.3B$113.5B
Dividend yieldn/a3.20%
Rank by revenue in sector#245 of 523 · Health care#21 of 523 · Health care

Over the years

Revenue
AXGN FY2018: $83.9MAXGN FY2019: $106.7MAXGN FY2020: $112.3MAXGN FY2021: $127.4MAXGN FY2022: $138.6MAXGN FY2023: $159MAXGN FY2024: $187.3MAXGN FY2025: $225.2MMDT FY2019: $30.6BMDT FY2020: $28.9BMDT FY2021: $30.1BMDT FY2022: $31.7BMDT FY2023: $31.2BMDT FY2024: $32.4BMDT FY2025: $33.5BMDT FY2026: $36.4BFY18FY19FY20FY21FY22FY23FY24FY25FY26
AXGN $225.2MMDT $36.4B
Net income
AXGN FY2018: -$22.4MAXGN FY2019: -$29.1MAXGN FY2020: -$23.8MAXGN FY2021: -$27MAXGN FY2022: -$28.9MAXGN FY2023: -$21.7MAXGN FY2024: -$10MAXGN FY2025: -$15.7MMDT FY2019: $4.6BMDT FY2020: $4.8BMDT FY2021: $3.6BMDT FY2022: $5BMDT FY2023: $3.8BMDT FY2024: $3.7BMDT FY2025: $4.7BMDT FY2026: $4.8BFY18FY19FY20FY21FY22FY23FY24FY25FY26
AXGN -$15.7MMDT $4.8B
Net margin
AXGN FY2018: -26.7%AXGN FY2019: -27.3%AXGN FY2020: -21.2%AXGN FY2021: -21.2%AXGN FY2022: -20.9%AXGN FY2023: -13.7%AXGN FY2024: -5.3%AXGN FY2025: -7.0%MDT FY2019: 15.2%MDT FY2020: 16.6%MDT FY2021: 12.0%MDT FY2022: 15.9%MDT FY2023: 12.0%MDT FY2024: 11.4%MDT FY2025: 13.9%MDT FY2026: 13.2%FY18FY19FY20FY21FY22FY23FY24FY25FY26
AXGN -7.0%MDT 13.2%
Revenue growth
AXGN FY2019: +27.1%AXGN FY2020: +5.2%AXGN FY2021: +13.4%AXGN FY2022: +8.8%AXGN FY2023: +14.7%AXGN FY2024: +17.8%AXGN FY2025: +20.2%MDT FY2020: -5.4%MDT FY2021: +4.2%MDT FY2022: +5.2%MDT FY2023: -1.4%MDT FY2024: +3.6%MDT FY2025: +3.6%MDT FY2026: +8.4%FY19FY20FY21FY22FY23FY24FY25FY26
AXGN +20.2%MDT +8.4%
Free cash flow
AXGN FY2018: -$24.1MAXGN FY2019: -$24.5MAXGN FY2020: -$31.5MAXGN FY2021: -$41.2MAXGN FY2022: -$36.1MAXGN FY2023: -$19.6MAXGN FY2024: $1.4MAXGN FY2025: -$2.9MMDT FY2019: $5.9BMDT FY2020: $6BMDT FY2021: $4.9BMDT FY2022: $6BMDT FY2023: $4.6BMDT FY2024: $5.2BMDT FY2025: $5.2BMDT FY2026: $5.4BFY18FY19FY20FY21FY22FY23FY24FY25FY26
AXGN -$2.9MMDT $5.4B

Fiscal years as each company reports them; the two may end in different months.

Questions about Axogen and Medtronic

Which is bigger by revenue, Axogen or Medtronic?

Medtronic is bigger by revenue: $36.4B in fiscal 2026, against $225.2M for Axogen in fiscal 2025.

Which keeps more of its revenue as profit, Axogen or Medtronic?

Axogen had a net margin of -7.0% in fiscal 2025; Medtronic had 13.2% in fiscal 2026.

Which grew revenue faster, Axogen or Medtronic?

In their latest fiscal years revenue changed by +20.2% at Axogen and +8.4% at Medtronic.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies